Daiichi Sankyo is buying control of India’s Ranbaxy Laboratories in a friendly takeover that could be worth as much as $4.6 billion.
Under the terms of the deal, the Japanese drugmaker will acquire the 34.8% controlling stake of Ranbaxy's founders, the Singh family, and make an open offer for a further 20% of the Gurgaon-based firm’s shares. The purchase price represents a premium of 53.5% to Ranbaxy’s average daily closing price on India’s National Stock Exchange for the three months ending on June 10, 2008 and up 31.4% on yesterday.
More
No comments:
Post a Comment